Table 2.
HGSOCs | Comparison | P‐value | HR | HR (95% CI) | P adj | |
---|---|---|---|---|---|---|
Lower | Upper | |||||
Overall Survival | ||||||
cluster B vs A | 0.003 | 0.15 | 0.03 | 0.81 | 0.03 | |
FIGO stage | 8.32 | 1.55 | 44.61 | 0.01 | ||
6q24.2–6q26 | 0.001 | 0.06 | 0.01 | 0.43 | 0.005 | |
FIGO stage | 10.80 | 1.67 | 69.70 | 0.01 | ||
5‐yrs survival | ||||||
cluster B vs A | 0.004 | 0.15 | 0.03 | 0.81 | 0.03 | |
FIGO stage | 8.29 | 1.54 | 44.75 | 0.01 | ||
6q24.2–6q26 | 0.002 | 0.06 | 0.01 | 0.43 | 0.005 | |
FIGO stage | 10.79 | 1.67 | 69.81 | 0.01 |
P‐values in the univariate analysis calculated with log‐rank test; Padj as calculated in multivariate analysis with Cox regression model with Overall Survival (OS) and 5‐year survival as endpoints. FIGO stage (high, ≥III; low, I&II), HR, Hazard Ratio; CI, Confidence Interval, significant P‐values (<0.05) for the tested variable are highlighted in bold and italics.